Citations

Citations to this article as recorded by  

• Buty and the beast: the complex role of butyrate in Parkinson’s disease
  Joshua D. Elford, Nanette Becht, Johan Garssen, Aletta D. Kraneveld, Paula Perez-Pardo
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Acupuncture ameliorates depression-like behavior of poststroke depression model rats through the regulation of gut microbiota and NLRP3 inflammasome in the colon
  Wa Cai, Xi-Fang Wei, Jing-Ruo Zhang, Larissa Tao, Dong Li, Kun Zhang, Wei-Dong Shen
  NeuroReport.2024;[Epub]     CrossRef
• Intestinal Barrier Function and Neurodegenerative Disease
  Shijing Wu, Liangfang Yang, Yiwei Fu, Zhimin Liao, De Cai, Zhou Liu
  CNS & Neurological Disorders - Drug Targets.2024; 23(9): 1134.     CrossRef
• The Role of the Gut Microbiota in Sanfilippo Syndrome’s Physiopathology: An Approach in Two Affected Siblings
  Raquel Barbero-Herranz, María Garriga-García, Ana Moreno-Blanco, Esther Palacios, Pedro Ruiz-Sala, Saioa Vicente-Santamaría, Sinziana Stanescu, Amaya Belanger-Quintana, Guillem Pintos-Morell, Beatriz Arconada, Rosa del Campo, José Avendaño-Ortiz
  International Journal of Molecular Sciences.2024; 25(16): 8856.     CrossRef
• Adipose tissue, systematic inflammation, and neurodegenerative diseases
  AnaPaula de A. Boleti, PedroHenrique de O. Cardoso, BrenoEmanuel F. Frihling, PatríciaSouza e Silva, LuizFilipe R. N. de Moraes, Ludovico Migliolo
  Neural Regeneration Research.2023; 18(1): 38.     CrossRef
• Parkinson's Disease: A Multisystem Disorder
  Helena Nunes Costa, Ana Raquel Esteves, Nuno Empadinhas, Sandra Morais Cardoso
  Neuroscience Bulletin.2023; 39(1): 113.     CrossRef
• Brain modulation by the gut microbiota: From disease to therapy
  Sarmistha Mitra, Raju Dash, Amena Al Nishan, Sarmin Ummey Habiba, Il Soo Moon
  Journal of Advanced Research.2023; 53: 153.     CrossRef
• Plasma Metabolic Analysis Reveals the Dysregulation of Short-Chain Fatty Acid Metabolism in Parkinson’s Disease
  Ao Qi, Lulu Liu, Junjie Zhang, Simei Chen, Simin Xu, Yusen Chen, Lijiang Zhang, Chun Cai
  Molecular Neurobiology.2023; 60(5): 2619.     CrossRef
• Fecal microbiota transplantation in Parkinson's disease—A randomized repeat-dose, placebo-controlled clinical pilot study
  Herbert L. DuPont, Jessika Suescun, Zhi-Dong Jiang, Eric L. Brown, Heather T. Essigmann, Ashley S. Alexander, Andrew W. DuPont, Tehseen Iqbal, Netanya S. Utay, Michael Newmark, Mya C. Schiess
  Frontiers in Neurology.2023;[Epub]     CrossRef
• Mesoporous silica nanoparticles: Their potential as drug delivery carriers and nanoscavengers in Alzheimer's and Parkinson's diseases
  Mohamed S. Attia, Ahmed Yahya, Nada Abdel Monaem, Shereen A. Sabry
  Saudi Pharmaceutical Journal.2023; 31(3): 417.     CrossRef
• GSDMD in peripheral myeloid cells regulates microglial immune training and neuroinflammation in Parkinson's disease
  Bingwei Wang, Yan Ma, Sheng Li, Hang Yao, Mingna Gu, Ying Liu, You Xue, Jianhua Ding, Chunmei Ma, Shuo Yang, Gang Hu
  Acta Pharmaceutica Sinica B.2023; 13(6): 2663.     CrossRef
• Gut-microbiome-brain axis: the crosstalk between the vagus nerve, alpha-synuclein and the brain in Parkinson’s disease
  Júlio César Claudino dos Santos, Leandro Freitas Oliveira, Felipe Micelli Noleto, Camilla Teixeira Pinheiro Gusmão, Gerly Anne de Castro Brito, Glauce Socorro de Barros Viana
  Neural Regeneration Research.2023; 18(12): 2611.     CrossRef
• Beyond the Microbiota: Understanding the Role of the Enteric Nervous System in Parkinson’s Disease from Mice to Human
  Martina Montanari, Paola Imbriani, Paola Bonsi, Giuseppina Martella, Antonella Peppe
  Biomedicines.2023; 11(6): 1560.     CrossRef
• Effects of gut microbiota on neurodegenerative diseases
  Saima Khatoon, Nida Kalam, Summya Rashid, Gulnaz Bano
  Frontiers in Aging Neuroscience.2023;[Epub]     CrossRef
• From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research Purposes
  Frances Widjaja, Ivonne M. C. M. Rietjens
  Biomedicines.2023; 11(10): 2658.     CrossRef
• Association between the risk and severity of Parkinson’s disease and plasma homocysteine, vitamin B12 and folate levels: a systematic review and meta-analysis
  Yuxin Quan, Jisen Xu, Qing Xu, Zhiqing Guo, Ruwei Ou, Huifang Shang, Qianqian Wei
  Frontiers in Aging Neuroscience.2023;[Epub]     CrossRef
• Oral pathogens exacerbate Parkinson’s disease by promoting Th1 cell infiltration in mice
  Xue-Bing Bai, Shuo Xu, Lu-Jun Zhou, Xiao-Qian Meng, Yu-Lin Li, Yan-Lin Chen, Yi-Han Jiang, Wen-Zhen Lin, Bo-Yan Chen, Lin-Juan Du, Guo-Cai Tian, Yan Liu, Sheng-Zhong Duan, Ya-Qin Zhu
  Microbiome.2023;[Epub]     CrossRef
• The intestinal luminal sources of α-synuclein: a gastroenterologist perspective
  Aaron Lerner
  Nutrition Reviews.2022; 80(2): 282.     CrossRef
• Mild Chronic Colitis Triggers Parkinsonism in LRRK2 Mutant Mice Through Activating TNF‐α Pathway
  Chin‐Hsien Lin, Han‐Yi Lin, En‐Pong Ho, Yi‐Ci Ke, Mei‐Fang Cheng, Chyng‐Yann Shiue, Chi‐Han Wu, Peng‐Hsiang Liao, Angela Yu‐Huey Hsu, Li‐An Chu, Ya‐Ding Liu, Ya‐Hui Lin, Yi‐Cheng Tai, Chia‐Tung Shun, Han‐Mo Chiu, Ming‐Shiang Wu
  Movement Disorders.2022; 37(4): 745.     CrossRef
• Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson’s disease
  Ehraz Anis, Aoji Xie, Lena Brundin, Patrik Brundin
  Trends in Endocrinology & Metabolism.2022; 33(2): 147.     CrossRef
• Animal models of brain-first and body-first Parkinson's disease
  Nathalie Van Den Berge, Ayse Ulusoy
  Neurobiology of Disease.2022; 163: 105599.     CrossRef
• Microbiome Changes in Humans with Parkinson’s Disease after Photobiomodulation Therapy: A Retrospective Study
  Brian Bicknell, Ann Liebert, Craig S. McLachlan, Hosen Kiat
  Journal of Personalized Medicine.2022; 12(1): 49.     CrossRef
• Passive Immunization in Alpha-Synuclein Preclinical Animal Models
  Jonas Folke, Nelson Ferreira, Tomasz Brudek, Per Borghammer, Nathalie Van Den Berge
  Biomolecules.2022; 12(2): 168.     CrossRef
• Dietary Succinoglycan Riclin Improves Glycemia Control in Mice with Type 2 Diabetes
  Zhao Ding, Yang Zhao, Junhao Liu, Wenhao Ge, Xi Xu, Shiming Wang, Jianfa Zhang
  Journal of Agricultural and Food Chemistry.2022; 70(6): 1819.     CrossRef
• Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling
  Sevag Hamamah, Armin Aghazarian, Anthony Nazaryan, Andras Hajnal, Mihai Covasa
  Biomedicines.2022; 10(2): 436.     CrossRef
• Distribution of α-Synuclein Aggregation in the Peripheral Tissues
  Yan-yan Li, Tian-tian Zhou, Yi Zhang, Nai-Hong Chen, Yu-He Yuan
  Neurochemical Research.2022; 47(12): 3627.     CrossRef
• Effects of Subdiaphragmatic Vagotomy in the MPTP-induced Neurotoxicity in the Striatum and Colon of Mice
  Jiajing Shan, Youge Qu, Jiancheng Zhang, Li Ma, Kenji Hashimoto
  Clinical Psychopharmacology and Neuroscience.2022; 20(2): 389.     CrossRef
• Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies
  Mie Kristine Just, Hjalte Gram, Vasileios Theologidis, Poul Henning Jensen, K. Peter R. Nilsson, Mikael Lindgren, Karoline Knudsen, Per Borghammer, Nathalie Van Den Berge
  Frontiers in Aging Neuroscience.2022;[Epub]     CrossRef
• Urolithins: potential biomarkers of gut dysbiosis and disease stage in Parkinson's patients
  María Romo-Vaquero, Emiliano Fernández-Villalba, Ana-Luisa Gil-Martinez, Lorena Cuenca-Bermejo, Juan Carlos Espín, María Trinidad Herrero, María Victoria Selma
  Food & Function.2022; 13(11): 6306.     CrossRef
• Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson’s disease
  Hiroshi Nishiwaki, Mikako Ito, Tomonari Hamaguchi, Tetsuya Maeda, Kenichi Kashihara, Yoshio Tsuboi, Jun Ueyama, Takumi Yoshida, Hiroyuki Hanada, Ichiro Takeuchi, Masahisa Katsuno, Masaaki Hirayama, Kinji Ohno
  npj Parkinson's Disease.2022;[Epub]     CrossRef
• Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson’s Disease “Off” Episodes
  Amnon A. Berger, Ariel Winnick, Jonathan Izygon, Binil M. Jacob, Jessica S. Kaye, Rachel J. Kaye, Elisa E. Neuchat, Adam M. Kaye, Edward S. Alpaugh, Elyse M. Cornett, Andrew H. Han, Alan D. Kaye
  Health Psychology Research.2022;[Epub]     CrossRef
• The role of LRRK2 in the periphery: link with Parkinson's disease and inflammatory diseases
  George Tsafaras, Veerle Baekelandt
  Neurobiology of Disease.2022; 172: 105806.     CrossRef
• What Is the Prognostic Significance of Rapid Eye Movement Sleep Without Atonia in a Polysomnogram?
  Frank Ralls, Lisa Cutchen, Madeleine M. Grigg-Damberger
  Journal of Clinical Neurophysiology.2022; 39(5): 346.     CrossRef
• Lippia grata essential oil complexed with β-cyclodextrin ameliorates biochemical and behavioral deficits in an animal model of progressive parkinsonism
  Jose Ivo A. Beserra-Filho, Amanda Maria-Macêdo, Suellen Silva-Martins, Ana Cláudia Custódio-Silva, Beatriz Soares-Silva, Sara Pereira Silva, Rafael Herling Lambertucci, Adriano Antunes de Souza Araújo, Angélica Maria Lucchese, Lucindo J. Quintans-Júnior,
  Metabolic Brain Disease.2022; 37(7): 2331.     CrossRef
• Oral and gut dysbiosis leads to functional alterations in Parkinson’s disease
  Sungyang Jo, Woorim Kang, Yun Su Hwang, Seung Hyun Lee, Kye Won Park, Mi Sun Kim, Hyunna Lee, Hyung Jeong Yoon, Yoo Kyoung Park, Mauricio Chalita, Je Hee Lee, Hojun Sung, Jae-Yun Lee, Jin-Woo Bae, Sun Ju Chung
  npj Parkinson's Disease.2022;[Epub]     CrossRef
• Deciphering Intertwined Molecular Pathways Underlying Metabolic Syndrome Leading to Parkinson’s Disease
  Ritu Soni, Jigna Shah
  ACS Chemical Neuroscience.2022; 13(15): 2240.     CrossRef
• Therapeutic potential of short-chain fatty acid production by gut microbiota in neurodegenerative disorders
  Sarika Yadav, Ashish Dwivedi, Anurag Tripathi, Amit Kumar Tripathi
  Nutrition Research.2022; 106: 72.     CrossRef
• Development of neurodegenerative disorders and the role of gut
  Woong-Woo Lee
  Journal of Geriatric Neurology.2022; 1(2): 53.     CrossRef
• What Are the Key Gut Microbiota Involved in Neurological Diseases? A Systematic Review
  Bruno Bonnechère, Najaf Amin, Cornelia van Duijn
  International Journal of Molecular Sciences.2022; 23(22): 13665.     CrossRef
• Gut microbiota in dementia with Lewy bodies
  Hiroshi Nishiwaki, Jun Ueyama, Kenichi Kashihara, Mikako Ito, Tomonari Hamaguchi, Tetsuya Maeda, Yoshio Tsuboi, Masahisa Katsuno, Masaaki Hirayama, Kinji Ohno
  npj Parkinson's Disease.2022;[Epub]     CrossRef
• Gut dysbiosis in stroke and its implications on Alzheimer’s disease‐like cognitive dysfunction
  Justin Cho, You Jeong Park, Bella Gonzales‐Portillo, Madeline Saft, Blaise Cozene, Nadia Sadanandan, Cesar V. Borlongan
  CNS Neuroscience & Therapeutics.2021; 27(5): 505.     CrossRef
• Plasma Lipopolysaccharide-Binding Protein Reflects Risk and Progression of Parkinson’s Disease
  Szu-Ju Chen, Yu-Chiao Chi, Chang-Han Ho, Wei-Shiung Yang, Chin-Hsien Lin
  Journal of Parkinson's Disease.2021; 11(3): 1129.     CrossRef
• Parkinson's disease and the gut: Models of an emerging relationship
  Adam J. Bindas, Subhash Kulkarni, Ryan A. Koppes, Abigail N. Koppes
  Acta Biomaterialia.2021; 132: 325.     CrossRef
• Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats
  Nathalie Van Den Berge, Nelson Ferreira, Trine Werenberg Mikkelsen, Aage Kristian Olsen Alstrup, Gültekin Tamgüney, Páll Karlsson, Astrid Juhl Terkelsen, Jens Randel Nyengaard, Poul Henning Jensen, Per Borghammer
  Brain.2021; 144(6): 1853.     CrossRef
• Desulfovibrio Bacteria Are Associated With Parkinson’s Disease
  Kari E. Murros, Vy A. Huynh, Timo M. Takala, Per E. J. Saris
  Frontiers in Cellular and Infection Microbiology.2021;[Epub]     CrossRef
• “Janus-Faced” α-Synuclein: Role in Parkinson’s Disease
  Bipul Ray, Arehally M. Mahalakshmi, Sunanda Tuladhar, Abid Bhat, Asha Srinivasan, Christophe Pellegrino, Anbarasu Kannan, Srinivasa Rao Bolla, Saravana Babu Chidambaram, Meena Kishore Sakharkar
  Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
• Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease
  Jonas Ghyselinck, Lynn Verstrepen, Frédéric Moens, Pieter Van Den Abbeele, Arnout Bruggeman, Jawal Said, Barry Smith, Lynne Ann Barker, Caroline Jordan, Valentina Leta, K. Ray Chaudhuri, Abdul W. Basit, Simon Gaisford
  International Journal of Pharmaceutics: X.2021; 3: 100087.     CrossRef
• The Role of The Gut Microbiome in Parkinson’s Disease
  Amy Gallop, James Weagley, Saif-ur-Rahman Paracha, George Grossberg
  Journal of Geriatric Psychiatry and Neurology.2021; 34(4): 253.     CrossRef
• The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson’s Disease
  Gianfranco Natale, Larisa Ryskalin, Gabriele Morucci, Gloria Lazzeri, Alessandro Frati, Francesco Fornai
  Life.2021; 11(8): 732.     CrossRef
• Regulation of neurotoxicity in the striatum and colon of MPTP-induced Parkinson’s disease mice by gut microbiome
  Jiajing Shan, Youge Qu, Siming Wang, Yan Wei, Lijia Chang, Li Ma, Kenji Hashimoto
  Brain Research Bulletin.2021; 177: 103.     CrossRef
• Cholecystectomy and subsequent risk of Parkinson’s disease: a nationwide retrospective cohort study
  Ryul Kim, Jee-Young Lee, Sanghyun Park, Kyungdo Han, Cheol Min Shin
  npj Parkinson's Disease.2021;[Epub]     CrossRef
• Benefits of Helicobacter pylori Eradication on Extragastric Diseases
  Tae Jun Kim, Hyuk Lee
  The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(4): 275.     CrossRef
• Higher cerebrospinal fluid to plasma ratio of p-cresol sulfate and indoxyl sulfate in patients with Parkinson’s disease
  Bartłomiej Sankowski, Karolina Księżarczyk, Emilia Raćkowska, Stanisław Szlufik, Dariusz Koziorowski, Joanna Giebułtowicz
  Clinica Chimica Acta.2020; 501: 165.     CrossRef
• The microbiome-gut-brain axis in acute and chronic brain diseases
  Corinne Benakis, Camille Martin-Gallausiaux, Jean-Pierre Trezzi, Philip Melton, Arthur Liesz, Paul Wilmes
  Current Opinion in Neurobiology.2020; 61: 1.     CrossRef
• The progress of gut microbiome research related to brain disorders
  Sibo Zhu, Yanfeng Jiang, Kelin Xu, Mei Cui, Weimin Ye, Genming Zhao, Li Jin, Xingdong Chen
  Journal of Neuroinflammation.2020;[Epub]     CrossRef
• Minireview on the Relations between Gut Microflora and Parkinson’s Disease: Further Biochemical (Oxidative Stress), Inflammatory, and Neurological Particularities
  Ovidiu-Dumitru Ilie, Alin Ciobica, Jack McKenna, Bogdan Doroftei, Ioannis Mavroudis, Tuane B. Sampaio
  Oxidative Medicine and Cellular Longevity.2020; 2020: 1.     CrossRef
• Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?
  Carolina Pellegrini, Luca Antonioli, Vincenzo Calderone, Rocchina Colucci, Matteo Fornai, Corrado Blandizzi
  Progress in Neurobiology.2020; 191: 101806.     CrossRef
• Meta‐Analysis of Gut Dysbiosis in Parkinson's Disease
  Hiroshi Nishiwaki, Mikako Ito, Tomohiro Ishida, Tomonari Hamaguchi, Tetsuya Maeda, Kenichi Kashihara, Yoshio Tsuboi, Jun Ueyama, Teppei Shimamura, Hiroshi Mori, Ken Kurokawa, Masahisa Katsuno, Masaaki Hirayama, Kinji Ohno
  Movement Disorders.2020; 35(9): 1626.     CrossRef
• In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
  Maria Fouka, Panagiota Mavroeidi, Grigoria Tsaka, Maria Xilouri
  Frontiers in Cell and Developmental Biology.2020;[Epub]     CrossRef
• Role of Carbon Monoxide in Host–Gut Microbiome Communication
  Christopher P. Hopper, Ladie Kimberly De La Cruz, Kristin V. Lyles, Lauren K. Wareham, Jack A. Gilbert, Zehava Eichenbaum, Marcin Magierowski, Robert K. Poole, Jakob Wollborn, Binghe Wang
  Chemical Reviews.2020; 120(24): 13273.     CrossRef
• Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
  Chrysoula Marogianni, Maria Sokratous, Efthimios Dardiotis, Georgios M. Hadjigeorgiou, Dimitrios Bogdanos, Georgia Xiromerisiou
  International Journal of Molecular Sciences.2020; 21(22): 8421.     CrossRef
• Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson’s Disease
  Tennekoon B. Karunaratne, Chijioke Okereke, Marissa Seamon, Sharad Purohit, Chandramohan Wakade, Amol Sharma
  Nutrients.2020; 13(1): 28.     CrossRef
• Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder
  Hiroshi Nishiwaki, Tomonari Hamaguchi, Mikako Ito, Tomohiro Ishida, Tetsuya Maeda, Kenichi Kashihara, Yoshio Tsuboi, Jun Ueyama, Teppei Shimamura, Hiroshi Mori, Ken Kurokawa, Masahisa Katsuno, Masaaki Hirayama, Kinji Ohno, Chaysavanh Manichanh
  mSystems.2020;[Epub]     CrossRef
• The Intestinal Barrier in Parkinson’s Disease: Current State of Knowledge
  Sven C. D. van IJzendoorn, Pascal Derkinderen, Teus van Laar
  Journal of Parkinson's Disease.2019; 9(s2): S323.     CrossRef
• Medical management, prevention and mitigation of environmental risks factors in Neurology
  J. Reis, G.C. Román, M. Giroud, V.S. Palmer, P.S. Spencer
  Revue Neurologique.2019; 175(10): 698.     CrossRef
• Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain
  Yaoyu Pu, Lijia Chang, Youge Qu, Siming Wang, Kai Zhang, Kenji Hashimoto
  Aging.2019; 11(17): 6915.     CrossRef